Controlled medication denaturing composition and method

Abstract

In one aspect, a composition for decomposing pharmaceutically active agents comprises an oxidizer comprising a permanganate, and an isocyanurate; and an immobilizer. In another aspect, a composition comprises up to 50 wt. % of an oxidizer comprising potassium permanganate and sodium dichloroisocyanurate dehydrate, wherein the wt. % is based on a total weight of the composition.

1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . A method of degrading a pharmaceutically active ingredient, comprising:
 placing the pharmaceutically active ingredient in the composition of  claim 1 ; and   degrading the pharmaceutically active ingredient.   
     
     
         17 . The method of  claim 16 , wherein the pharmaceutically active ingredient is a US Drug Enforcement Agency identified schedule I, II, III, IV, and/or V controlled substance. 
     
     
         18 . The method of  claim 16 , wherein degrading the pharmaceutically active ingredient comprising rendering the pharmaceutically active ingredient non-retrievable as defined by the US Drug Enforcement Agency under 21 C.F.R. § 1300.05. 
     
     
         19 . The method of  claim 16 , further comprising adding water to the composition of  claim 1 . 
     
     
         20 . The method of  claim 16 , wherein the pharmaceutically active ingredient is degraded within two hours after being placed in the composition of  claim 1 .